The lack of large-sample studies evaluating the expression of different ER isoforms using isoform-specific antibodies (ERα, ERβ, and GPER) likely contributes to the inconsistency of published results concerning ERs expression in PAAD [9]. The gene discussed is ESR2; the disease is pancreatic adenocarcinoma.